Anaeropharma Science
Tokyo
About Anaeropharma Science
Anaeropharma Science was established in 2004 to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, recombinant bifidobacterium therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $49.2M
- Last round: Series Unknown (Jan 2020)
- Website: anaeropharma.co.jp
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/anaeropharma-science-128043 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.